Introduction Therapy-related severe myeloid leukemia happens like a complication of treatment with chemotherapy, radiotherapy, immunosuppressive providers or contact with environmental carcinogens. agent, cyclophosphamide and DNA topoisomerase II inhibitor, doxorubicin and adjuvant radiotherapy. Cytogenetic evaluation exposed a 46, XX, deletion 7 (q22q34), deletion 20 (q11.2q13.1) karyotype in five out of 20 metaphases and inversion 16 was […]